HC21 News

Announcing Strategic Partnership to Advance GI Cancer Treatment in the UK

DMAC Support •

Aquilant is excited to announce a new partnership with Mirai Medical to bring the innovative EndoVE system to gastrointestinal (GI) clinicians across the UK. This collaboration marks a significant step forward in the treatment of colorectal cancer, particularly for patients with inoperable disease.

EndoVE, powered by Mirai’s proprietary ePORE® technology, delivers precise, non-thermal ablation via endoscopic pulsed electric fields. This approach targets tumours while preserving surrounding healthy tissue, offering a safe, fast, and effective solution for GI disease management.

“We’re delighted to partner with Aquilant to bring our endoscopic pulsed electric field platform to GI clinicians across the UK,” said Declan Soden, CEO of Mirai Medical. “Together, we’re advancing gastrointestinal cancer treatment and improving outcomes for patients.”

David Atkinson, Business Development Director at Healthcare 21, added: “Aquilant is delighted to partner with Mirai to promote the ground-breaking EndoVE technology. This collaboration represents a shared commitment to advancing patient care, particularly in enhancing palliative outcomes for those living with colorectal cancer. Together, we aim to bring innovative solutions that make a meaningful difference in patients’ lives.”

Learn more about EndoVE
here


ukcompliance@hc21.group

HC21 HC21 News Newsletter Quality
Related News
HC21 News

Highlights from the first Paediatric Networking Study Day

The first Paediatric Networking Study Day took place at Edgbaston Cricket Ground in Birmingham, bringing together paediatric theatre professionals for a day of practical learning and open discussion.

HC21 News
HC21 News

Xograph Showcases the Future of Dental Imaging at Snetterton

Xograph Healthcare, part of HC21 UK, was delighted to join the British Superbike Championship at Snetterton alongside colleagues from Planmeca, bringing the latest developments in dental and maxillofacial imaging to visitors.

HC21 News
HC21 News

Innovation in Focus: NanoKnife IRE at King’s College Hospital

Dr Praveen Peddu of King’s College Hospital NHS Foundation Trust has shared his insights into the use of NanoKnife irreversible electroporation (IRE) technology from AngioDynamics International and its expanding application in cancer treatment.

HC21 News
Choose Your Region

This helps us show the right products, services, and contact details.